about
World Health Organization essential medicines lists: where are the drugs to treat neuropathic pain?Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern Africans.Resilience does not explain the dissociation between chronic pain and physical activity in South Africans living with HIV.HIV-associated sensory neuropathy: risk factors and genetics.Painful HIV-associated sensory neuropathy.Pharmacological treatment of painful HIV-associated sensory neuropathy.Diagnosing and treating HIV-associated sensory neuropathy: a global perspective.Genetics of HIV-associated sensory neuropathy and related pain in Africans.Psychological Factors Associated With Painful Versus Non-Painful HIV-Associated Sensory Neuropathy.Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patients.TNF Block Gene Variants Associate With Pain Intensity in Black Southern Africans With HIV-associated Sensory Neuropathy.KCNS1, but not GCH1, is associated with pain intensity in a black southern African population with HIV-associated sensory neuropathy: a genetic association study.TNF haplotypes in a Southern African population resemble those seen in Caucasians and Asians.HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.Predictors of Cold and Pressure Pain Tolerance in Healthy South African Adults.Analysis of a previously identified "pain-protective" haplotype and individual polymorphisms in the GCH1 gene in Africans with HIV-associated sensory neuropathy: a genetic association study.A polymorphism in IL4 may associate with sensory neuropathy in African HIV patients.Polymorphisms in uncoupling protein genesUCP2andUCP3are not associated with HIV-associated sensory neuropathy in African individualsA preliminary analysis of the association between perceived stigma and HIV-related pain in South Africans living with HIV
P50
Q27004578-C8F4EF8B-2FA8-42E4-9889-76E9CDAC391EQ33874791-26E568C1-7970-4805-B496-1B85A5C0BF31Q35079928-84ACAC84-886A-4165-BD27-33BFC3B6E1DAQ37267218-DC2CEC4F-FE53-49E6-ADD0-2BD896D2A759Q37988382-12937283-36B1-49BA-8B0A-DFB6249BAD63Q38197249-6016FC7A-5E01-48C1-86F2-CD6304B62E5BQ38597412-B5E40037-74FB-4D9C-A8B9-D7622BC5A78DQ38778861-844D838C-476F-4DAE-A53A-11804D5F7B93Q39339843-2AE5D0E2-FF32-408C-BEA1-FE59C2FA09A3Q40133910-BAEBF6A8-A9C1-4651-A20E-5405E81E5209Q40826704-E24A8804-F610-4CAA-B249-8CAEAB6E1DA4Q41440466-DE2EE8A4-4D8C-4DA1-9752-DCBA01BBC849Q44297950-313515CA-921A-4EEE-8ADE-C479A7D5CCE0Q46092358-16BF44F5-2BF5-448B-8467-9C0E979E04C8Q46610471-99C05CE7-0731-459E-8450-F867D867A818Q47892134-20D8B7B1-AFB1-491E-A8C2-817F91F6CEB4Q48682392-D20856BA-9DC4-403B-A5B4-6C317BDE73CAQ48970951-459AED1D-8AE7-4B78-9893-C4CA986E9335Q60731119-46237613-009E-4DE0-A068-044BAF57E70DQ64246578-919EC323-DE89-40B1-811B-E2EA45E669A0
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonia L Wadley
@es
Antonia L Wadley
@nl
Antonia L Wadley
@sl
Antonia L. Wadley
@en
type
label
Antonia L Wadley
@es
Antonia L Wadley
@nl
Antonia L Wadley
@sl
Antonia L. Wadley
@en
prefLabel
Antonia L Wadley
@es
Antonia L Wadley
@nl
Antonia L Wadley
@sl
Antonia L. Wadley
@en
P106
P1153
36187510800
P21
P31
P496
0000-0001-5654-0047
P569
2000-01-01T00:00:00Z